IL325832A - פורמולציות ושימושים של מעכבי rock2 ל- als - Google Patents

פורמולציות ושימושים של מעכבי rock2 ל- als

Info

Publication number
IL325832A
IL325832A IL325832A IL32583226A IL325832A IL 325832 A IL325832 A IL 325832A IL 325832 A IL325832 A IL 325832A IL 32583226 A IL32583226 A IL 32583226A IL 325832 A IL325832 A IL 325832A
Authority
IL
Israel
Prior art keywords
als
formulations
rock2 inhibitors
rock2
inhibitors
Prior art date
Application number
IL325832A
Other languages
English (en)
Original Assignee
Graviton Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Graviton Bioscience Bv filed Critical Graviton Bioscience Bv
Publication of IL325832A publication Critical patent/IL325832A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL325832A 2023-07-17 2024-07-17 פורמולציות ושימושים של מעכבי rock2 ל- als IL325832A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363514039P 2023-07-17 2023-07-17
PCT/IB2024/056935 WO2025017499A1 (en) 2023-07-17 2024-07-17 Formulations and uses of rock2 inhibitors for als

Publications (1)

Publication Number Publication Date
IL325832A true IL325832A (he) 2026-03-01

Family

ID=92302394

Family Applications (1)

Application Number Title Priority Date Filing Date
IL325832A IL325832A (he) 2023-07-17 2024-07-17 פורמולציות ושימושים של מעכבי rock2 ל- als

Country Status (3)

Country Link
AU (1) AU2024292342A1 (he)
IL (1) IL325832A (he)
WO (1) WO2025017499A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026053168A1 (en) * 2024-09-06 2026-03-12 Graviton Bioscience Bv Amorphous forms of a rock2 inhibitor and formulations thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005723A1 (fr) 1988-11-24 1990-05-31 Yoshitomi Pharmaceutical Industries, Ltd. Composes de trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane et leur utilisation en medecine
DE4201178C2 (de) 1992-01-17 1995-12-07 Alfatec Pharma Gmbh Verfahren zur Herstellung von Weichgelatinekapseln nach einem Tropfverfahren
NL1009107C2 (nl) 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
JP2002529398A (ja) 1998-11-11 2002-09-10 バイオプログレス・テクノロジー・インターナショナル・インコーポレイテッド 薬剤配達系のためのカプセル
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
ES2387780T3 (es) 2003-10-06 2012-10-01 Glaxosmithkline Llc Preparación de azabencimidazoles 1,6-disustituidos como inhibidores de quinasas
US7592357B2 (en) 2004-02-20 2009-09-22 Smithkline Beecham Corporation Compounds
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
PT1905452E (pt) 2005-07-12 2013-07-16 Kowa Co Agente para a prevenção ou tratamento do glaucoma
GB0704932D0 (en) 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
WO2011130740A2 (en) 2010-04-16 2011-10-20 H. Lee Moffitt Cancer Center And Research Institute, Inc. Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
CN113620933A (zh) 2012-10-05 2021-11-09 卡德门企业有限公司 Rho激酶抑制剂
US11311541B2 (en) 2014-04-09 2022-04-26 Kadmon Corporation, Llc Treatment of GVHD
CN110582489B (zh) 2017-06-30 2023-10-27 北京泰德制药股份有限公司 Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
WO2019000682A1 (zh) 2017-06-30 2019-01-03 北京泰德制药股份有限公司 Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
US10323023B2 (en) 2017-06-30 2019-06-18 Beijing Tide Pharmaceutical Co., Ltd. Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
GB201801226D0 (en) 2018-01-25 2018-03-14 Redx Pharma Plc Modulators of Rho-associated protein kinase
CN112969694B (zh) 2018-11-09 2023-06-13 北京泰德制药股份有限公司 Rho相关蛋白激酶抑制剂、包含其的药物组合物及其用途
BR112021017354A2 (pt) 2019-03-01 2021-11-16 Beijing Tide Pharmaceutical Co Ltd Método para o tratamento de doença hepática adiposa e/ou esteatoepatite
CA3144113A1 (en) 2019-06-25 2020-12-30 Beijing Tide Pharmaceutical Co., Ltd. Method for treating idiopathic pulmonary fibrosis
KR20230058466A (ko) 2020-08-31 2023-05-03 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 신규한 rho-연관 단백질 인산화효소 억제제의 제조 방법 및 제조 방법 중의 중간체
JP2023539276A (ja) * 2020-08-31 2023-09-13 ベイジン タイド ファーマシューティカル カンパニー リミテッド Ｒｈｏ関連タンパク質キナーゼ阻害剤の塩、その固体形態、その調製方法およびその使用
JP7284355B1 (ja) 2021-09-30 2023-05-30 京セラ株式会社 電気化学セル、電気化学セル装置、モジュールおよびモジュール収容装置
KR20240095429A (ko) * 2021-11-16 2024-06-25 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 Rock2 억제제의 나노결정 제제 및 이의 제조방법
CN120882712A (zh) 2022-11-21 2025-10-31 格雷威顿生物科技有限公司 Rock2抑制剂

Also Published As

Publication number Publication date
AU2024292342A1 (en) 2026-02-26
WO2025017499A1 (en) 2025-01-23

Similar Documents

Publication Publication Date Title
IL320739A (he) מעכבי rock2
GB2595975B (en) Inhibitors of cysteine proteases and methods of use thereof
IL316616A (he) מעכבי rock2
EP4143196A4 (en) PI3K-A INHIBITORS AND METHODS OF USE THEREOF
IL318169A (he) מעכבי Apol1 ושיטות שימוש זהות
IL321357A (he) מעכבי kif18a ושימושים שלהם
EP4370124A4 (en) PI3KA INHIBITORS AND METHODS OF USE THEREOF
IL310812A (he) צורות מוצקות של מעכבי apol1 spirotricyclic ושיטות שימושן
IL325832A (he) פורמולציות ושימושים של מעכבי rock2 ל- als
CA3251244A1 (en) PI3K-ALPHA INHIBITORS AND THEIR METHODS OF USE
EP4448514A4 (en) TYK2 INHIBITORS AND ASSOCIATED COMPOSITIONS AND PROCESSES
IL310209A (he) מעכבי rock2 ושימושים שלהם
IL316049A (he) תכשירי רוקחות של מוסונטוזומאב ושיטות לשימוש
EP4329735A4 (en) KCNT1 INHIBITORS AND METHODS OF USE
GB2617793B (en) Selective inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof
CA3263153A1 (en) KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE
CA3298098A1 (en) Formulations and uses of rock2 inhibitors for als
ZA202109296B (en) Formulations and preparations for prevention and treatment of covid-19 and flu therefor
IL325831A (he) פורמולציות של מעכבי rock2 עבור הפרעות במערכת העצבים המרכזית
CA3265653A1 (en) ULK INHIBITORS AND THEIR METHODS OF USE
CA3273444A1 (en) Inhibitors of rock2
HK40122640A (en) Inhibitors of rock2
PT4136091T (pt) Formas e composições de inibidores da calicreína plasmática
CA3298108A1 (en) Formulations of rock2 inhibitors for cns disorders
HK40120733A (en) Class of prmt5 inhibitors and use thereof